A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy
Launched by BROOKE ARMY MEDICAL CENTER · Aug 5, 2009
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients referred to our clinic for average or increased risk screening for colorectal cancer
- Exclusion Criteria:
- • elevated serum creatinine (Men \>1.4mg/dL, Women \>1.3mg/dL)
- • previous diagnosis of congestive heart failure
- • history of bowel obstruction
- • history of solid organ transplant
- • current pregnancy
- • lactating mother
- • participants allergic to either polyethylene glycol (Miralax), lubiprostone (Amitiza), or bisacodyl (Dulcolax)
About Brooke Army Medical Center
Brooke Army Medical Center (BAMC) is a premier military medical facility located in San Antonio, Texas, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a leading sponsor of clinical trials, BAMC leverages its expertise in trauma care, surgical interventions, and military medicine to evaluate new treatments and therapies aimed at improving patient outcomes. The center's multidisciplinary team of healthcare professionals and researchers collaborates to uphold the highest standards of ethical conduct and scientific integrity, ensuring that all trials contribute valuable insights to the medical community and enhance the quality of care for service members and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials